ID

20618

Descrizione

Local Registration Trial in China Humalog Mix 50; ODM derived from: https://clinicaltrials.gov/show/NCT00191581

collegamento

https://clinicaltrials.gov/show/NCT00191581

Keywords

versioni (1)
  1. 06/03/17 06/03/17 -
Caricato su

6 marzo 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Diabetes Mellitus, Type 1 NCT00191581

Inglese

Eligibility Diabetes Mellitus, Type 1 NCT00191581

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. men and women who have had either type 1 or type 2 diabetes (world health organization[who]classification)for at least 2 months and are between the ages of 18 and 70 (inclusive) at the signing of the informed consent.
Descrizione

Age | Insulin-Dependent Diabetes Mellitus disease length | Non-Insulin-Dependent Diabetes Mellitus disease length

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2,1]
C0011854
UMLS CUI [2,2]
C0872146
UMLS CUI [3,1]
C0011860
UMLS CUI [3,2]
C0872146
2. have been treated with commercially available human insulin mix 50/50 or human insulin mix 30/70 twice daily as the only pharmacological treatment for their diabetes for at least 2 months prior to entering the study.
Descrizione

Insulin regime

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0557978
3. have an hba1c between 1.1 and 1.7 times the upper limit of the normal reference rang(inclusive) as determined by a local laboratory within 2 weeks prior to or at visit 1.
Descrizione

Increased HbA1c levels

Tipo di dati

boolean

Alias
UMLS CUI [1]
C4073162
4. have achieved compliance with their diets and insulin therapies as determined by the investigators and perform regular blood glucose monitoring.
Descrizione

Compliance behavior | Diet therapy | Insulin regime | Blood Glucose Self-Monitoring

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1321605
UMLS CUI [2]
C0012159
UMLS CUI [3]
C0557978
UMLS CUI [4]
C0005803
5. have given informed consent to participate in this study in accordance with local regulations.
Descrizione

Informed Consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
{1] have used oral antidiabetic agents, including biguanides, sulfonylureas, glucosidase inhibitors, and insulin-sensitivity enhancers within 30 days prior to entry into the study.
Descrizione

Antidiabetics Oral | Biguanides | Sulfonylurea Compounds | Glucosidase Inhibitor | Enhanced insulin sensitivity

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
UMLS CUI [2]
C0005382
UMLS CUI [3]
C0038766
UMLS CUI [4]
C1512211
UMLS CUI [5]
C3549878
[2] receive a total daily dose of insulin >2 units/kg.
Descrizione

Insulin Cumulative Dose Unit/kilogram/day

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C2986497
UMLS CUI [1,3]
C1532634
[3] have had more than two episodes of severe hypoglycemia (defined as requiring assistance of another person due to disabling hypoglycemia) within 6 months prior to entry into the study.
Descrizione

Hypoglycemia Severe Episode Quantity | Hypoglycemia Disabling Requirement Assistance

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0020615
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0332189
UMLS CUI [1,4]
C1265611
UMLS CUI [2,1]
C0020615
UMLS CUI [2,2]
C4061999
UMLS CUI [2,3]
C1514873
UMLS CUI [2,4]
C1269765
[4] have a body mass index >35 kg/m2.
Descrizione

Body mass index

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1305855
[5] have serum creatinine > the upper limit of normal (uln), as determined by a local laboratory.
Descrizione

Serum creatinine raised

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0700225
Ritorna all'inizio della pagina

Similar models

Eligibility Diabetes Mellitus, Type 1 NCT00191581

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Age | Insulin-Dependent Diabetes Mellitus disease length | Non-Insulin-Dependent Diabetes Mellitus disease length
Item
1. men and women who have had either type 1 or type 2 diabetes (world health organization[who]classification)for at least 2 months and are between the ages of 18 and 70 (inclusive) at the signing of the informed consent.
boolean
C0001779 (UMLS CUI [1])
C0011854 (UMLS CUI [2,1])
C0872146 (UMLS CUI [2,2])
C0011860 (UMLS CUI [3,1])
C0872146 (UMLS CUI [3,2])
Insulin regime
Item
2. have been treated with commercially available human insulin mix 50/50 or human insulin mix 30/70 twice daily as the only pharmacological treatment for their diabetes for at least 2 months prior to entering the study.
boolean
C0557978 (UMLS CUI [1])
Increased HbA1c levels
Item
3. have an hba1c between 1.1 and 1.7 times the upper limit of the normal reference rang(inclusive) as determined by a local laboratory within 2 weeks prior to or at visit 1.
boolean
C4073162 (UMLS CUI [1])
Compliance behavior | Diet therapy | Insulin regime | Blood Glucose Self-Monitoring
Item
4. have achieved compliance with their diets and insulin therapies as determined by the investigators and perform regular blood glucose monitoring.
boolean
C1321605 (UMLS CUI [1])
C0012159 (UMLS CUI [2])
C0557978 (UMLS CUI [3])
C0005803 (UMLS CUI [4])
Informed Consent
Item
5. have given informed consent to participate in this study in accordance with local regulations.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Antidiabetics Oral | Biguanides | Sulfonylurea Compounds | Glucosidase Inhibitor | Enhanced insulin sensitivity
Item
{1] have used oral antidiabetic agents, including biguanides, sulfonylureas, glucosidase inhibitors, and insulin-sensitivity enhancers within 30 days prior to entry into the study.
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0005382 (UMLS CUI [2])
C0038766 (UMLS CUI [3])
C1512211 (UMLS CUI [4])
C3549878 (UMLS CUI [5])
Insulin Cumulative Dose Unit/kilogram/day
Item
[2] receive a total daily dose of insulin >2 units/kg.
boolean
C0021641 (UMLS CUI [1,1])
C2986497 (UMLS CUI [1,2])
C1532634 (UMLS CUI [1,3])
Hypoglycemia Severe Episode Quantity | Hypoglycemia Disabling Requirement Assistance
Item
[3] have had more than two episodes of severe hypoglycemia (defined as requiring assistance of another person due to disabling hypoglycemia) within 6 months prior to entry into the study.
boolean
C0020615 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0332189 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,4])
C0020615 (UMLS CUI [2,1])
C4061999 (UMLS CUI [2,2])
C1514873 (UMLS CUI [2,3])
C1269765 (UMLS CUI [2,4])
Body mass index
Item
[4] have a body mass index >35 kg/m2.
boolean
C1305855 (UMLS CUI [1])
Serum creatinine raised
Item
[5] have serum creatinine > the upper limit of normal (uln), as determined by a local laboratory.
boolean
C0700225 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial